Matching slides 119,566
Current window 67,021-67,050
Pages 3,986
Rows per page 30
Component: Imageclear collectionreset all

Component

67,021-67,050 of 119,566

filter-aware
333
The slide uses a 'fraud-exposure' framework by juxtaposing management quotes against physical site inspection findings.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
334
The slide uses visual evidence to debunk the progress of the 'Phase 2' construction project.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
01
Slide 1
Includes a YouTube link referencing the film 'Spinal Tap' as a metaphor for the company's technology.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
11
The slide uses a combination of narrative text, a testimonial quote, and a bar chart to link high-volume implanters to high payments.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The MonsterLoop · The Reveal1 hit
26
Uses emotional appeal and external media (Netflix documentary, NYT review) to frame the subject as a villain.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
31
The slide uses a 'three-point' narrative structure to build a case against the company's safety record.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
34
Uses social proof/anecdotal evidence to undermine company claims of safety.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
35
The slide uses direct quotes from social media to build a case against the product's efficacy and patient experience.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
36
The slide uses a 'villain' framing technique by aggregating negative user experiences to undermine the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
37
Uses graphic imagery and patient testimonials to frame the company's product as dangerous and the medical practice as profit-driven.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
38
The slide uses anecdotal evidence (patient social media posts) to frame the company's product as a 'hustle' or 'quackery'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
39
The slide uses screenshots of Facebook posts to build a narrative of corporate negligence and product failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
40
The slide uses anecdotal evidence from Facebook support groups to build a negative narrative about the company's product performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
59
The slide uses a visual aid of a standard pain scale to highlight the subjectivity of the clinical trial's primary endpoint.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
72
The slide highlights a specific clinical study (PROCO) to undermine the competitive advantage of the subject company's core technology.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
74
Includes a quote from a 'West coast-based high volume implanter' and a visual annotation of study results.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
75
The slide uses a quote from a former Medtronic employee to reinforce the argument that the technology is not unique or effective.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
78
Uses direct quotes from company filings and website to frame the 'paresthesia-free' claim as a vulnerability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
84
The slide uses a screenshot of a Nevro investor presentation to expose a contradiction in their reported explant rates.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
85
The slide uses a screenshot of a medical journal article to highlight author conflicts of interest and a table of explant data to challenge the company's claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
86
The slide uses a red circle to highlight a specific table from a medical paper, emphasizing the discrepancy between real-world outcomes and company claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
130
Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
164
Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
207
The slide uses a direct quote and a news headline to substantiate the claim of unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
208
Includes source links to a German-language publication (SonntagsBlick) and Google Translate versions.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
213
Uses a screenshot of an official government document to frame the company's business model as fraudulent.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
218
The slide uses inflammatory language ('cesspool', 'exploitation') to frame the company as a villain.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
237
The slide uses a screenshot of a social media post as primary evidence to support the claim of unauthorized practice of medicine.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
09
Uses a screenshot of a CNBC interview to highlight a perceived lie by the CEO regarding lock-up expirations.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
10
Uses historical analogy to frame the company as a speculative bubble.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit